The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates

Neurochemical Research

Volumn 37, Issue 12, 2012, Pages 2659-2666

  Zhang, Suojun ^a,b   Luo, Xiao ^b   Wan, Feng ^a,b   Lei, Ting ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Glioma stem cells; Gliomas; Hypoxia inducible factors; Migration; Neural stem cells

Indexed keywords

CHEMOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MATRIX METALLOPROTEINASE; MESSENGER RNA; VASCULOTROPIN;

CANCER RECURRENCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL SURVIVAL; CHEMOTAXIS; CYTOLOGY; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GLIOMA CELL; GROWTH REGULATION; HUMAN; HYPOXEMIA; MOLECULAR BIOLOGY; NEURAL STEM CELL; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TARGET CELL; TROPISM; TUMOR MICROENVIRONMENT; UPREGULATION;

BRAIN NEOPLASMS; CELL LINEAGE; CELL MOVEMENT; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS;

EID: 84871403430     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0879-x     Document Type: Review

References (99)

1. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin 60(3):166-193
2. Galli R, Binda E, Orfanelli U et al (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64(19):7011-7021
3. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432(7015):396-401
4. Yuan X, Curtin J, Xiong Y et al (2004) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23(58): 9392-9400
5. Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756-760
6. Eramo A, Ricci-Vitiani L, Zeuner A et al (2006) Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 13(7): 1238-1241
7. Campos B, Wan F, Farhadi M et al (2010) Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 16(10):2715-2728
8. Das B, Tsuchida R, Malkin D, Koren G, Baruchel S, Yeger H (2008) Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 26(7):1818-1830
9. Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN (2009) The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8(20):3274-3284
10. Li Z, Bao S, Wu Q et al (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15(6):501-513
11. McCord AM, Jamal M, Shankavaram UT, Lang FF, Camphausen K, Tofilon PJ (2009) Physiologic oxygen concentration enhances the stem-like properties of CD133? human glioblastoma cells in vitro. Mol Cancer Res 7(4):489-497
12. Soeda A, Park M, Lee D et al (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28(45):3949-3959
13. Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG (2010) Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177(3): 1491-1502
14. Seidel S, Garvalov BK, Wirta V et al (2010) A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain 133(Pt 4):983-995
15. Platet N, Liu SY, Atifi ME et al (2007) Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett 258(2):286-290
16. Moeller BJ, Cao Y, Li CY, Dewhirst MW (2004) Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Roleof reoxygenation, free radicals, and stress granules. Cancer Cell 5(5):429-441
17. Blazek ER, Foutch JL, Maki G (2007) Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133-cells, and the CD133 ? sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys 67(1):1-5
18. Rich JN (2007) Cancer stem cells in radiation resistance. Cancer Res 67(19):8980-8984
19. Sheehan JP, Shaffrey ME, Gupta B, Larner J, Rich JN, Park DM (2010) Improving the radiosensitivity of radioresistant and hypoxic glioblastoma. Future Oncol 6(10):1591-1601
20. Liang BC (1996) Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J Neurooncol 29(2): 149-155
21. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP (2002) Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62(12):3387-3394
22. Zhang W, Zhang H (2006) Hypoxia-inducible factor-1alpha suppressing apoptosis and increasing tolerance of lung cancer cells to chemotherapy. J Huazhong Univ Sci Technolog Med Sci 26(5):520-523
23. Kolenda J, Jensen SS, Aaberg-Jessen C et al (2011) Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J Neurooncol 103(1):43-58
24. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721-732
25. Cairns RA, Papandreou I, Sutphin PD, Denko NC (2007) Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy. Proc Natl Acad Sci USA 104(22): 9445-9450
26. Gillespie DL, Whang K, Ragel BT, Flynn JR, Kelly DA, Jensen RL (2007) Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates humanglioma cell growth in vivo. Clin Cancer Res 13(8):2441-2448
27. Mendez O, Zavadil J, Esencay M et al (2010) Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer 9:133
28. Staflin K, Honeth G, Kalliomaki S, Kjellman C, Edvardsen K, Lindvall M (2004) Neural progenitor cell lines inhibit rat tumor growth in vivo. Cancer Res 64(15):5347-5354
29. Glass R, Synowitz M, Kronenberg G et al (2005) Glioblastomainduced attraction of endogenous neural precursor cells is associated with improved survival. J Neurosci 25(10):2637-2646
30. Luo J, Zhang L, Tu H et al (2007) Experimental study on treatment of glioma by embryonic neural stem cell transplantation in rats. J Huazhong Univ Sci Technolog Med Sci 27(5):571-575
31. Tyler MA, Ulasov IV, Sonabend AM et al (2009) Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther 16(2):262-278
32. Kim SU (2011) Neural stem cell-based gene therapy for brain tumors. Stem Cell Rev 7(1):130-140
33. Xu Q, Wang S, Jiang X et al (2007) Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro. Clin Exp Pharmacol Physiol 34(7):624-631
34. Rosova I, Dao M, Capoccia B, Link D, Nolta JA (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26(8):2173-2182
35. Liu H,Xue W, Ge G et al (2010)Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha inMSCs. Biochem Biophys Res Commun 401(4):509-515
36. Lee SH, Lee YJ, Han HJ (2011) Role of hypoxia-induced fibronectin-integrin beta1 expression in embryonic stem cell proliferation and migration: Involvement of PI3 K/Akt and FAK. J Cell Physiol 226(2):484-493
37. Raheja LF, Genetos DC, Wong A, Yellowley CE (2011) Hypoxic regulation of mesenchymal stem cell migration: The role of RhoA and HIF-1alpha. Cell Biol Int 35(10):981-989
38. Zhao D, Najbauer J, Garcia E et al (2008) Neural stem cell tropism to glioma: Critical role of tumor hypoxia. Mol Cancer Res 6(12):1819-1829
39. Ingraham CA, Park GC, Makarenkova HP, Crossin KL (2011) Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels. J Biol Chem 286(20):17649-17657
40. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38-47
41. Keith B, Simon MC (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129(3):465-472
42. Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441(7092):437-443
43. Schioppa T, Uranchimeg B, Saccani A et al (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198(9): 1391-1402
44. Piovan E, Tosello V, Indraccolo S et al (2007) Differential regulation of hypoxia-induced CXCR4 triggering during B-celldevelopment and lymphomagenesis. Cancer Res 67(18):8605-8614
45. Wang X, Li C, Chen Y et al (2008) Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alphaactivation. Biochem Biophys Res Commun 371(2):283-288
46. Kubo M, Li TS, Kamota T, Ohshima M, Qin SL, Hamano K (2009) Increased expression of CXCR4 and integrin alphaM in hypoxia-preconditioned cellscontributes to improved cell retention and angiogenic potency. J Cell Physiol 220(2):508-514
47. Cronin PA, Wang JH, Redmond HP (2010) Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4. BMC Cancer 10:225
48. Raval RR, Lau KW, TranMGet al (2005) Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindauassociated renal cell carcinoma. Mol Cell Biol 25(13):5675-5686
49. Freed CR, Breeze RE, Rosenberg NL et al (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327(22):1549-1555
50. Spencer DD, Robbins RJ, Naftolin F et al (1992) Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327(22):1541-1548
51. Baetge EE (1993) Neural stem cells for CNS transplantation. Ann N Y Acad Sci 695:285-291
52. Armstrong RJ, Svendsen CN (2000) Neural stem cells: From cell biology to cell replacement. Cell Transplant 9(2):139-152
53. Temple S (2001) The development of neural stem cells. Nature 414(6859):112-117
54. Imitola J, Raddassi K, Park KI et al (2004) Directed migration of neural stem cells to sites of CNS injury by the stromal cellderived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 101(52):18117-18122
55. Zhu J, Zhou L, XingWu F (2006) Tracking neural stem cells in patients with brain trauma. N Engl J Med 355(22):2376-2378
56. Carbajal KS, Schaumburg C, Strieter R, Kane J, Lane TE (2010) Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci USA 107(24):11068-11073
57. Aboody KS, Brown A, Rainov NG et al (2000) Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA 97(23): 12846-12851
58. Benedetti S, Pirola B, Pollo B et al (2000) Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 6(4):447-450
59. Herrlinger U, Woiciechowski C, Sena-Esteves M et al (2000) Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther 1(4):347-357
60. Yip S, Sabetrasekh R, Sidman RL, Snyder EY (2006) Neural stem cells as novel cancer therapeutic vehicles. Eur J Cancer 42(9):1298-1308
61. Aboody KS, Najbauer J, Danks MK (2008) Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 15(10): 739-752
62. Ahmed AU, Alexiades NG, Lesniak MS (2010) The use of neural stem cells in cancer gene therapy: Predicting the path to the clinic. Curr Opin Mol Ther 12(5):546-552
63. Hung SC, Pochampally RR, Hsu SC et al (2007) Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE 2(5):e416
64. Wang Y, Deng Y, Zhou GQ (2008) SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 1195:104-112
65. Tang YL, Zhu W, Cheng M et al (2009) Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104(10):1209-1216
66. Ceradini DJ, Kulkarni AR, Callaghan MJ et al (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10(8):858-864
67. Chang YC, Shyu WC, Lin SZ, Li H (2007) Regenerative therapy for stroke. Cell Transplant 16(2):171-181
68. Schmidt NO, Przylecki W, Yang W et al (2005) Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 7(6):623-629
69. Zhang X, Gaspard JP, Chung DC (2001) Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 61(16):6050-6054
70. Wu B, Crampton SP, Hughes CC (2007) Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26(2):227-239
71. Mazumdar J, O'Brien WT, Johnson RS et al (2010) O2 regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol 12(10):1007-1013
72. Lamszus K, Lengler U, Schmidt NO, Stavrou D, Ergun S, Westphal M (2000) Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 46(4):938-947 (Discussion 947-948
73. Horie N, So K, Moriya T et al (2008) Effects of oxygen concentration on the proliferation and differentiation of mouse neural stem cells in vitro. Cell Mol Neurobiol 28(6):833-845
74. Zhao T, Zhang CP, Liu ZH et al (2008) Hypoxia-driven proliferation of embryonic neural stem/progenitor cells-role of hypoxia-inducible transcription factor-1alpha. FEBS J 275(8): 1824-1834
75. Clarke L (2009) v. Low oxygen enhances primitive and definitive neural stem cell colony formation by inhibiting distinct cell death pathways. Stem Cells 27(8):1879-1886
76. Panchision DM (2009) The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol 220(3): 562-568
77. Chen X, Tian Y, Yao L, Zhang J, Liu Y (2010) Hypoxia stimulates proliferation of rat neural stem cells with influence on the expression of cyclin D1 and c-Jun N-terminal protein kinase signaling pathway in vitro. Neuroscience 165(3):705-714
78. De Filippis L, Delia D (2011) Hypoxia in the regulation of neural stem cells. Cell Mol Life Sci 68(17):2831-2844
79. Lian JH, Pennant WA, Hyung LM et al (2011) Neural stem cells modified by a hypoxia-inducible VEGF gene expression system improve cell viability under hypoxic conditions and spinal cord injury. Spine (Phila Pa 1976) 36(11):857-864
80. Studer L, Csete M, Lee SH et al (2000) Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20(19):7377-7383
81. Zhang CP, Zhu LL, Zhao T et al (2006) Characteristics of neural stem cells expanded in lowered oxygen and the potential role of hypoxia-inducible factor-1Alpha. Neurosignals 15(5):259-265
82. Santilli G, Lamorte G, Carlessi L et al (2010) Mild hypoxia enhances proliferation and multipotency of human neural stem cells. PLoS ONE 5(1):e8575
83. Pistollato F, Chen HL, Schwartz PH, Basso G, Panchision DM (2007) Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes. Mol Cell Neurosci 35(3):424-435
84. Gustafsson MV, Zheng X, Pereira T et al (2005) Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9(5):617-628
85. Pistollato F, Rampazzo E, Persano L et al (2010) Interaction of hypoxia-inducible factor-1alpha and Notch signaling regulates medulloblastoma precursor proliferation and fate. Stem Cells 28(11):1918-1929
86. Mukherjee T, Kim WS, Mandal L, Banerjee U (2011) Interaction between Notch and Hif-alpha in development and survival of Drosophila blood cells. Science 332(6034):1210-1213
87. Takeuchi H, Natsume A, Wakabayashi T et al (2007) Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1-and HGF-dependent manner. Neurosci Lett 426(2):69-74
88. Fujiwara Y, Tanaka N, Ishida O et al (2004) Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci Lett 366(3):287-291
89. Vescovi AL, Galli R, Reynolds BA (2006) Brain tumour stem cells. Nat Rev Cancer 6(6):425-436
90. Calabrese C, Poppleton H, Kocak M et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11(1):69-82
91. Fine HA (2009) Glioma stem cells: Not all created equal. Cancer Cell 15(4):247-249
92. Alcantara LSR, Chen Y, McKay RM, Parada LF (2011) Stem cells in brain tumor development. Curr Top Dev Biol 94:15-44
93. Gillespie DL, Whang K, Ragel BT, Flynn JR, Kelly DA, Jensen RL (2007) Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res 13(8):2441-2448
94. Pietras A, Johnsson AS, Pahlman S (2010) The HIF-2alpha-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization. Curr Top Microbiol Immunol 345: 1-20
95. Covello KL, Kehler J, Yu H et al (2006) HIF-2alpha regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 20(5):557-570
96. Loboda A, Jozkowicz A, Dulak J (2010) HIF-1 and HIF-2 transcription factors-similar but not identical. Mol Cells 29(5): 435-442
97. Bar EE (2011) Glioblastoma, cancer stem cells and hypoxia. Brain Pathol 21(2):119-129
98. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC (2007) HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11(4):335-347
99. Krishnamurthy P, Ross DD, Nakanishi T et al (2004) The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 279(23):24218-24225